Literature DB >> 17620209

Psychometric properties of the Hamilton Depression Rating Scale and other physician-rated psychiatric scales for the assessment of depression in ESRD patients undergoing hemodialysis in Turkey.

Faruk Gençöz1, Tülin Gençöz, Attila Soykan.   

Abstract

This study aimed to examine the reliability and validity of clinician-rated psychiatric scales for end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) treatment in Turkey. For this, the Hamilton Depression Rating Scale (HDRS), Hamilton Anxiety Rating Scale (HARS), Global Assessment of Functioning (GAF) Scale, Clinical Global Impression (CGI) Scale, and Mini Mental State Exam (MMSE) were administered to 45 ESRD outpatients undergoing HD treatment. Regarding the reliability of HDRS and HARS, internal consistency and split-half reliability analyses revealed acceptable coefficients. The test - retest reliability coefficients were also examined for all measures after a period of a month, and despite this relatively long time interval, test - retest reliability coefficients were above .60 for all measures. Concerning the validity studies, all these scales revealed suitable convergent, discriminant, and criterion validity outcomes. A cut-off point of 10 for HDRS is suggested for the identification of depression in this population. In general, the findings of this study indicate that HDRS, HARS, CGI, GAF, and MMSE are reliable and valid instruments that can be used among ESRD patients undergoing HD.

Entities:  

Mesh:

Year:  2007        PMID: 17620209     DOI: 10.1080/13548500600892054

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  7 in total

1.  Quality of life associated to chronic pelvic pain is independent of endometriosis diagnosis--a cross-sectional survey.

Authors:  Carlos A Souza; Luciano M Oliveira; Camila Scheffel; Vanessa K Genro; Virginia Rosa; Marcia F Chaves; João S Cunha Filho
Journal:  Health Qual Life Outcomes       Date:  2011-06-10       Impact factor: 3.186

2.  Findings of multidimensional instruments for determining psychopathology in diabetic and non-diabetic hemodialysis patients.

Authors:  Gülperi Celik; Bilge Burçak Annagür; Mümtaz Yılmaz; Fatih Kara
Journal:  Int J Clin Exp Med       Date:  2012-08-22

3.  Alexithymia, Phosphorus Levels, and Sleep Disorders in Patients on Hemodialysis.

Authors:  Đorđe Pojatić; Dajana Nikić; Ivana Tolj; Davorin Pezerović; Andrijana Šantić; Dunja Degmečić
Journal:  J Clin Med       Date:  2022-06-05       Impact factor: 4.964

Review 4.  Understanding the Outcomes Measures used in Huntington Disease Pharmacological Trials: A Systematic Review.

Authors:  Noelle E Carlozzi; Angela Miciura; Nicholas Migliore; Praveen Dayalu
Journal:  J Huntingtons Dis       Date:  2014

5.  Effectiveness of group cognitive behavioral therapy with mindfulness in end-stage renal disease hemodialysis patients.

Authors:  Bo Kyung Sohn; Yun Kyu Oh; Jung-Seok Choi; Jiyoun Song; Ahyoung Lim; Jung Pyo Lee; Jung Nam An; Hee-Jeong Choi; Jae Yeon Hwang; Hee-Yeon Jung; Jun-Young Lee; Chun Soo Lim
Journal:  Kidney Res Clin Pract       Date:  2018-03-31

6.  Depression Screening Tools for Patients with Kidney Failure: A Systematic Review.

Authors:  Karli Kondo; Jennifer R Antick; Chelsea K Ayers; Devan Kansagara; Pavan Chopra
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-17       Impact factor: 8.237

7.  Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Authors:  Zaher Armaly; Joseph Farah; Adel Jabbour; Bishara Bisharat; Amir Abd-El Qader; Shahira Saba; Maha Zaher; Elia El Haj; Munir Hamzi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-25       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.